Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
9.47
-0.44 (-4.44%)
At close: Jul 11, 2025, 4:00 PM
9.48
+0.01 (0.11%)
After-hours: Jul 11, 2025, 7:04 PM EDT
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $304.89 million as of July 11, 2025. Its market cap has increased by 127.46% in one year.
Market Cap
304.89M
Enterprise Value
160.36M
1-Year Change
127.46%
Ranking
Category
Stock Price
$9.47
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $304.89M, a decrease of -14.07%. That is a compound annual growth rate of -7.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2025 | 319.06M | 120.22% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 706.13B |
| Johnson & Johnson | 373.81B |
| AbbVie | 335.16B |
| Novo Nordisk | 313.36B |
| UnitedHealth Group | 272.19B |
| Novartis AG | 240.15B |
| Abbott Laboratories | 229.05B |
| AstraZeneca | 217.48B |